Partners healthcare system
Boston medical center
Brigham and womens hospital
Dana farber cancer institute
Lawrence general hospital
Lowell general hospital
Massachusetts eye and ear infirmary
New england rehabilitation hospital
North shore medical center
Saints medical center
Spaulding rehabilitation hospital
St elizabeth medical center
Umass memorial medical center
Massachusetts Eye & Ear Infirmary
Massachusetts General Hospital
The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.
Dig. Dis. Sci., Feb;56(2):564-8 (2011)
Evolution of the New Pathway curriculum at Harvard Medical School: the new integrated curriculum.
Perspect. Biol. Med., 54(1):36-54 (2011)
A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
Gastroenterology., Jul;141(1):141-9 (2011)
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Hepatology., Aug;54(2):396-405 (2011)
Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians.
Acad Med., Jul;87(7):845-52 (2012)
Perspective: a culture of respect, part 2: creating a culture of respect.
Acad Med., Jul;87(7):853-8 (2012)
Hepatitis B virus infection.
N. Engl. J. Med., Oct;359(14):1486-500 (2008)
Benefits and risks of nucleoside analog therapy for hepatitis B.
Hepatology., May;49(5 Suppl):S112-21 (2009)
Commentary: Assessment is an educational tool.
Acad Med., May;84(5):548-50 (2009)
Perspective: Medical school admissions and noncognitive testing: some open questions.
Acad Med., Oct;84(10):1360-3 (2009)
Looking to the future: new agents for chronic hepatitis B.
Am. J. Gastroenterol., 101 Suppl 1:S19-25 (2006)
The role of liver biopsy in chronic hepatitis C.
Hepatology., Nov;36(5 Suppl 1):S152-60 (2002)
Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.
Clin Drug Investig., 27(1):35-49 (2007)
Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.
Transplantation., Nov;66(9):1254-8 (1998)
Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
Am. J. Gastroenterol., Jun;94(6):1619-26 (1999)
Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.
J. Med. Virol., Aug;58(4):353-8 (1999)
Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.
Hepatology., Oct;30(4):1082-7 (1999)
Lamivudine as initial treatment for chronic hepatitis B in the United States.
N. Engl. J. Med., Oct;341(17):1256-63 (1999)
Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
Am. J. Gastroenterol., Feb;97(2):478-83 (2002)
Histological outcome during long-term lamivudine therapy.
Gastroenterology., Jan;124(1):105-17 (2003)